I-Mab Biopharma
IMAB
#9307
Rank
ยฃ49.96 M
Marketcap
ยฃ0.60
Share price
-5.65%
Change (1 day)
-58.04%
Change (1 year)

Revenue for I-Mab Biopharma (IMAB)

Revenue in 2024 (TTM): ยฃ2.56 Million

According to I-Mab Biopharma's latest financial reports the company's current revenue (TTM ) is ยฃ2.43 Million. a decrease over the revenue in the year 2023 that were of ยฃ0.06 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for I-Mab Biopharma from 2017 to 2024

Annual revenue

Year Revenue Change
2024 N/A-100%
2023 ยฃ0.06 M-139.76%
2022-ยฃ0.17 Million-110.38%
2021ยฃ1.61 M-94.01%
2020 ยฃ26.96 M5798.4%
2019 ยฃ0.45 M-46.01%
2018 ยฃ0.84 M317.83%
2017ยฃ0.2 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ยฃ0.16 M-93.09%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.53 B 21,690.08%๐Ÿ‡บ๐Ÿ‡ธ USA